MTT Assay Assertion-Reason Analysis: DNA Fragmentation vs Tetrazolium Reduction

The MTT assay measures cell viability through mitochondrial activity, not DNA fragmentation. Understanding its true mechanism clarifies why the assertion-reason pairing is incorrect.

Correct Answer

Answer: (D) (a) is false but (r) is true

Assertion (a) incorrectly states MTT assay uses DNA fragmentation for color formation. Reason (r) correctly describes the actual mechanism: mitochondrial dehydrogenases reduce yellow soluble MTT to purple insoluble formazan, measured colorimetrically at 570 nm.

Option Analysis Table

Option Assertion (a) Reason (r) Relationship Correct?
(A) True True (r) explains (a) ❌ Wrong: (a) false
(B) True True (r) unrelated to (a) ❌ Wrong: (a) false
(C) True False ❌ Wrong: (r) true
(D) False True ✅ Correct

Assertion Analysis

Assertion (a): FALSE

MTT assay does NOT rely on DNA fragmentation. DNA fragmentation indicates apoptosis (programmed cell death), measured by other assays like TUNEL, Comet assay, or DNA laddering on gels. MTT measures metabolic activity of live cells.

Reason (r): TRUE

MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) is a yellow soluble tetrazolium salt. Live cells’ mitochondrial NAD(P)H-dependent oxidoreductases cleave the tetrazolium ring, forming purple water-insoluble formazan crystals. These are solubilized (DMSO/acid) for absorbance reading.

Reaction Mechanism

MTT (yellow, soluble)[NAD(P)H-dehydrogenases]Formazan (purple, insoluble)

Absorbance at 570 nm ∝ viable cell number

Complete MTT Assay Principle (6 Steps)

  1. Live cells have active mitochondria with dehydrogenases
  2. MTT added (0.5 mg/mL typically)
  3. Enzymatic reduction produces formazan crystals
  4. Solubilization with DMSO or isopropanol
  5. Colorimetric reading (OD570 – OD630)
  6. Viability % = (Sample OD / Control OD) × 100

Common Confusions

  • DNA fragmentation = apoptosis marker (TUNEL assay)
  • MTT/formazan = mitochondrial metabolism marker
  • LDH release = membrane integrity (another viability assay)
  • ATP content = luminescence-based viability (CellTiter-Glo)

Clinical/Research Applications

  • Cytotoxicity screening (drugs, nanoparticles)
  • Cell proliferation studies
  • IC50 determination
  • High-throughput 96-well format

The assay’s sensitivity to mitochondrial inhibitors and its inability to distinguish live/apoptotic/necrotic states are known limitations, but its principle remains tetrazolium reduction, not DNA fragmentation.